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Abstract
Background Long-term survival for all patients with os-
teosarcoma using current aggressive adjuvant chemotherapy
and surgical resection is between 60% and 70%. In patients
who present with nonmetastatic, high-grade extremity os-
teosarcoma of bone, limb salvage surgery is favored, when
appropriate, over amputation to preserve the limb, because
limb salvage may lead to a superior quality of life compared
with amputation. However, concern remains that in the at-
tempt to preserve the limb, close or microscopically positive
surgical margins may have an adverse effect on event-free
survival.
Questions/purposes (1) Does a positive or close surgical
margin increase the likelihood of a local recurrence? (2)
Does a positive or close surgical margin adversely affect
the development of metastatic disease? (3) What is the
relationship of surgical margin on overall survival?
Methods With institutional review board approval, we
retrospectively evaluated 241 patients treated at our insti-
tution between 1999 and 2011. Exclusion criteria included
nonextremity locations, metastatic disease at initial presen-
tation, low- or intermediate-grade osteosarcoma, treatment
regimens that did not follow National Comprehensive
Cancer Network (NCCN) guidelines, incomplete medical
records, and any part of treatment performed outside of
Moffitt Cancer Center or All Children’s Hospital. Fifty-one
patients were included in the final analysis, of whom 31
(61%) had followup data at a minimum of 2 years or whose
clinical status was known but had died before 2 years of
followup. Margin status was defined as (1) microscopically
positive; (2) negative B 1 mm; and (3) negative[ 1 mm.
Margin status, histologic response (tumor percent necrosis),
type of osteosarcoma, type of surgery, presence of local
recurrence, metastatic disease, and overall survival were
recorded for each patient. The mean age was 22 years
(range, 12–74 years) and the mean followup was 3 years
(range, 0.1–14 years). Margin status was positive in 10%
(five of 51), negative B 1 mm 26% (13 of 51), and negative
[ 1 mm 65% (33 of 51).
Results Local recurrencewas noted to be 14% (seven of 51)
at 3.4 years. After controlling for relevant confounding vari-
ables, the presence of a positive margin compared with a
negative margin[1 mm was the only independent predictor
of local recurrence (hazard ratio [HR], 8.006; 95% confidence
interval [CI], 1.314–48.781; p = 0.0241). At a mean of 3.4
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years, 29% (15 of 51) of the patients developed metastatic
disease with no difference with the numbers available in the
probability of developing metastatic disease among the three
margin groups (p = 0.614). Overall survival at 3.8 years was
75% (38 of 51). After controlling for relevant confounding
variables, we found that patients with positive margins were
more likely to die from disease than those with negative
margins (HR, 6.26; 95%CI, 1.50–26.14; p = 0.0119); no other
independent predictors of survival were identified.
Conclusions With the numbers of patients we had, we
observed that patients with extremity, nonmetastatic, high-
grade osteosarcoma who had positive margins showed a
higher probability of local recurrence in comparison to
those with negative surgical margins. Given that positive
margins appear to be associated with poorer survival in
patients with high-grade osteosarcoma of the extremities,
surgeons should strive to achieve negative margins, but
larger studies are needed to confirm these findings.
Level of Evidence Level III, therapeutic study.
Introduction
Overall survival in all patients with osteosarcoma using
currently accepted treatment modalities of neoadjuvant
chemotherapy, local surgical control, and adjuvant che-
motherapy is approximately 60% to 70% [4, 11]. Limb
preservation is preferred over amputation when possible for
local control because this may allow for increased function
and improved quality of life.
However, in the context of limb preservation surgery,
inadequate surgical margins have been associated with an in-
creased incidence of local recurrence in osteosarcoma, and the
smallest safemarginwidth still remains controversial. Because
local recurrence may adversely affect survival, this is a key
issue when considering limb-sparing resections. In one study
enrolling 837 patients with a combination of low- and high-
grade bone and soft tissue sarcomas, an adequate margin was
found to be 2 cm when the preoperative treatment modality
(chemotherapy or radiation) was effective as determined by a
marked decrease in size of the tumor on posttreatment imaging
before surgical resection. Histopathological correlation be-
tween tumor percent necrosis and local recurrence was not
done [9]. However, in a second study involving patients with
high-grade osteosarcoma that was nonmetastatic at presenta-
tion, there was no difference in local recurrence between
margins less than or equal to 2mmversusmore than 2mm [3].
With institutional review board approval we therefore
retrospectively studied our experience in patients with ex-
tremity, nonmetastatic, high-grade osteosarcoma in terms
of the impact of margin status on oncologic outcomes.
Specifically, we asked the following questions: (1) Does a
positive or close surgical margin increase the likelihood of
a local recurrence? (2) Does a positive or close surgical
margin adversely affect the development of metastatic
disease? (3) What is the relationship of surgical margin on
overall survival?
Patients and Methods
Demographics
From 1999 to 2011, we treated 241 patients at our insti-
tution for osteosarcoma. We excluded 90 (37%) patients
for incomplete medical records, 34 (14%) patients whose
primary site of disease was extraosseous or in a nonex-
tremity location, 35 (15%) patients in whom some of their
treatment was performed outside of H. Lee Moffitt Cancer
Center and All Children’s Hospital, 16 (7%) patients whose
treatment did not follow National Comprehensive Cancer
Network guidelines, seven (3%) patients whose disease
was of osseous origin in an extremity but not a long bone
(ie, hands and feet), five (2%) patients who had metastatic
disease at presentation, and three (1%) patients who had
low- or intermediate-grade histologies. Patients who had
died or reached another clinical endpoint before 2 years
and whose status was known were included. This left 51
(21%) patients who satisfied the prespecified study inclu-
sion and exclusion criteria (Fig. 1). All diagnoses were
confirmed histologically.
There were a total of 20 (39%) patients who had clinical
followup of less than 2 years. Of these, 16 (80%) were lost
to followup and four (20%) were secondary to death during
the followup period. All patients who were lost to death
before 2 years from surgery had positive margins. Of the
remaining 16 patients, five (31%) had close margins of 1
mm or less. There were no patients lost to followup, aside
from death, with positive margins. There were 31 (61%)
patients with a minimum followup of 2 years from the time
of surgery. Of these, eight (26%) had close margins of 1
mm or less and two (7%) had positive margins (Table 1).
After biopsy all patients underwent two cycles of
neoadjuvant chemotherapy with a three-drug regimen of
Adriamycin, cisplatin, and high-dose methotrexate [6].
After surgical wound healing from local control, patients
underwent between zero and four cycles of adjuvant che-
motherapy consisting of the same three-drug regimen in
Cycles 3 and 4 and only Adriamycin with high-dose
methotrexate in Cycles 5 and 6. The determination for
adjuvant chemotherapy was multifactorial and dependent
on factors such as patient age, histological response of the
tumor to the neoadjuvant treatment, and the discretion of
the medical and orthopaedic oncologists.
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Definitive surgery for local control was performed
within 4 weeks of the completion of neoadjuvant che-
motherapy. Forty-six patients underwent limb preservation
surgery (90%) and five patients underwent amputation
(10%) including three forequarter amputations and two
above-knee amputations. General indications for amputa-
tion in our patient cohort included major vascular
structures encased by tumor not amendable to vascular
bypass, extensive soft tissue involvement, or severe in-
fection within the surgical field that would have
compromised limb reconstruction.
In five patients with a microscopically positive margin,
three underwent reresection at the time of the initial sur-
gical procedure and two did not. Reresection at the time of
the initial operation was based on intraoperative frozen
section from a concerning area. Those who did not undergo
reresection did not have intraoperative frozen sections be-
cause it was felt at the time of surgery that the initial
resection was adequate for achieving negative surgical
margins. Postoperative radiation therapy was not given for
a microscopic positive margin. All positive margins in our
study were adjacent at an extraosseous soft tissue compo-
nent of the tumor. For purposes of statistical analysis, all
positive margins, whether determined intraoperatively with
frozen section or at the time of final pathology, were
grouped into the positive surgical margin group.
Patients were followed with both imaging and physical
examination every 3 months for the first 2 years after
surgery, every 6 months in the third year, and yearly in
Years 4 and 5. After this time followup duration was de-
termined at the discretion of the treating physician.
Imaging included plain radiographs and MRI with contrast
of the original tumor site as well as CT scan of the chest.
The attending pathologist (CMC, MB) determined the
final margin status. For the purposes of our study, margin
status was determined to be microscopically positive,
negative B 1 mm, or negative[ 1 mm. There were no
grossly positive resections in our patient cohort. All spe-
cimens were oriented and inked by the pathologist after
review with the operative surgeon. A microscopically
positive margin was reported when the tumor was present
Table 1. Comparison between patients with less than and minimum
2 years followup
Followup period Minimum
followup 2 years
Followup less than
2 years (excluding death)
Total number 31 16
Positive margins 2 (7%) 0 (0%)
Margins B 1 mm 8 (26%) 5 (31%)
Local recurrence 6 (19%) 1 (6%)
Metastatic disease 9 (29%) 6 (38%)
Initial Patient Cohort 
n = 241
Incomplete Medical Records (90)
n = 151
Nonextremity Locations (34)
n = 117
Performed Outside H. Lee Mofitt Cancer 
Center/All Children's Hospital (35)
n = 82
Treatment Outside NCCN Guidelines 
(16)
n = 66
Nonlong Bone Location (7)
n = 59
Metastatic Disease (5)
n = 54
Low/Intermediate Grade (3)
n = 51
Final Patient Cohort
Fig. 1 The flowchart shows exclusion criteria for our patient cohort.
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on the inked margin. Surgical margins were positive in five
of 51 patients (10%), negative B 1 mm in 13 of 51 (26%),
and negative[ 1 mm in 33 of 51 (65%).
When the margin was negative, the distance from the
tumor to the closest margin was measured.
Margin status, histologic response (percent tumor
necrosis), type of osteosarcoma, type of local control
surgery, presence of local recurrence, metastatic disease,
and overall survival were recorded for each patient
(Table 2). Tumor percent necrosis was determined using
the system developed by Huvos [8] by comparing the
biopsy and resected specimen to see the degree of
necrosis present. For two patients the tumor percent
necrosis was unavailable in the final pathology report.
Overall survival was determined by longevity from the
time of surgery until the time of death, if applicable. The
average age of our patient cohort was 22 years (range,
12–74 years) and the average followup was 3 years
(range, 0.1–14 years). Full demographic variables for each
of the three margin groups are provided (Table 3).
Statistics
Tumor percent necrosis (histological response), type of
osteosarcoma, and amputation versus limb preservation
were first investigated in their relation to margin status
using univariate analysis. The chi-square test using the
exact method with Monte Carlo estimation was performed
for all variables. Time zero was determined to be the date
of initial surgical resection. Local recurrence-free survival,
metastases-free survival, and overall survival were calcu-
lated with the Kaplan-Meier method with the log-rank test.
Cox proportional hazard models with forward selection at
Table 2. Listing of study variables
Variable Level Frequency Percent
Margin (grouped) Negative margins[ 1 mm 33 65
Negative margins B 1 mm 13 26
Positive margins 5 10
Tumor percent necrosis B 90% 28 57
[ 90% 21 43
Type of osteosarcoma Chondroblastic 11 22
Fibroblastic 1 2
Giant cell rich 2 4
Osteoblastic 31 61
Periosteal 2 4
Small cell 1 2
Telangiectatic 3 6
Amputation or limb salvage Amputation 5 10
Limb salvage 46 90
Vital status Alive 38 75
Dead 13 25
Local recurrence status Local recurrence 7 14
No local recurrence 44 86
Metastasis status Metastasis 15 29
No metastasis 36 71
Table 3. Demographics of study population
Demographic Positive
margins
Negative margins
[ 1 mm
Negative margins
B 1 mm
Age at diagnosis
(years)
28 22 21
Side
Left 2 24 5
Right 3 9 8
Sex
Male 2 19 5
Female 3 14 8
Location
Upper extremity 0 9 2
Lower extremity 5 24 11
Followup (months) 23 45 45
Size in largest
dimension (cm)
12 10 9
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inclusion a = 0.05 were used for multivariate analysis to
identify factors predictive of local recurrence and overall
survival. SAS software (SAS Institute, Inc, Cary, NC,
USA) was used for all statistical analysis.
Results
Local Recurrence
After controlling for relevant confounding variables, the
presence of a positive margin compared with a negative
margin [ 1 mm was the only independent predictor of
local recurrence (hazard ratio, 8.006; 95% confidence
interval [CI], 1.314–48.781; p = 0.0241). Negative
margins B 1 mm did not show an increased likelihood of
local recurrence in multivariate analysis with the num-
bers we had available for study (Table 4). Local
recurrence overall was 14% (seven of 51) at an average
of 3 years. Two-year local recurrence-free probability
for margins[ 1 mm was estimated to be 93% (95% CI,
0.85–1.0) versus 38% (95% CI, 0.08–1.0) for positive
margins (Fig. 2).
Metastatic Disease
With the numbers available, there was no difference in
probability of developing metastatic disease among the
three margin groups (p = 0.614). The metastatic disease
rate overall was 29% (15 of 51) at an average of 3.4 years.
Overall Survival
After adjusting for confounding variables, margin status was
the only variable significantly associated with overall sur-
vival and was found to be a negative predictor (Table 4).
Overall survival at an average of 4 years was 75% (38 of 51).
Two-year overall survival probability was shown to be 93%
(95%CI, 0.84–1.0) for negativemargins[1mmversus 40%
(95% CI, 0.14–1.0) for positive margins (Fig. 3).
Discussion
Although it has long been believed that a positive margin
portends a bad prognosis in osteosarcoma, the controversy
Table 4. Final multivariate models for local recurrence and overall survival
Variable Level compared with reference HR (95% CI) p value
Local recurrence
Margin grouped Negative margins B 1 mm 1.799 (0.3–10.786) 0.5205
Margin grouped Positive margins 8.006 (1.314–48.781) 0.0241
Overall survival
Margin grouped Negative margins B 1 mm 1.447 (0.361–5.804) 0.6024
Margin grouped Positive margins 6.26 (1.499–26.142) 0.0119
HR = hazard ratio; CI = confidence interval.
Fig. 2 The graph shows a Kaplan-Meier estimator curve for local
recurrence by margin status.
Fig. 3 The graph shows a Kaplan-Meier estimator curve of overall
survival by margin status.
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about how much margin is necessary remains. In this study
performed at a single institution allowing for consistency in
both medical and surgical treatment as well as histological
diagnosis of nonmetastatic osteosarcoma that originated in
the long bone, we found that a positive margin portended
an increased risk for local recurrence and overall worse
survival and were able to identify this difference although
we had relatively few patients in the series.
We recognize that there are several weaknesses to our
study that limit the impact of the conclusions. First, it was a
retrospective study not allowing us to capture all pertinent
information but only what was listed in the medical
records. We did have a significant portion of patients who
were excluded from the study secondary to incomplete
medical records relating to important endpoints to the study
such as time after surgery to local recurrence as well as
cause and date of death. If we were able to prospectively
collect this information in a more complete manner this
may have allowed for more patients to be included in the
final cohort, thus potentially increasing the power of our
study. Second, we did have a significant portion of patients
lost to followup, excluding death, before 2 years. The pa-
tients lost to followup were not more likely to have positive
margins in comparison to patients who had followup of a
minimum of 2 years; however, the incidence of close
margins B 1 mm was slightly higher in the lost to followup
group. One may argue that with the higher percentage of
close margins lost to followup that maybe these patients
had local recurrences or metastatic disease treated else-
where. However, we did not find in our study that close
negative margins were associated with worse probability
for local recurrence, development of metastatic disease, or
overall survival. We do admit that our short average fol-
lowup of just over 3 years may not allow for the detection
of local recurrence or metastatic disease that occurs later in
the disease process. Third, the low incidence of osteosar-
coma in the general patient population limits our study to
small patient numbers, even over a 12-year period. The low
proportion of patients treated at our institution who met the
inclusion criteria for our study, 51 out of a potential of 241
patients with osteosarcoma seen during the time period of
the study, also introduces the potential for selection bias to
our study. The early death of some patients may decrease
the actual number of local recurrences because these pa-
tients did not survive long enough to go on to develop a
local recurrence. We do concede that secondary to our low
patient numbers, our study is likely underpowered. Thus,
our findings of no difference in the development of
metastatic disease across the three margin groups was
likely underpowered because we did see a difference in
overall survival and we know that patients die of metastatic
disease with primary extremity osteosarcoma. Also, we
were unable to show a significant effect from response to
chemotherapy to either overall survival or local recurrence,
both of which were affected by tumor percent necrosis in
prior studies. This is likely secondary to our study being
underpowered with exclusion of patients secondary to our
strict inclusion criteria. Fourth, cause-specific mortality
was not included because death certificates were not
available for this study but only the date of death. This
could potentially bias our overall survival results because
patients could have died of other causes besides metastatic
disease. This may help explain discrepancies seen in our
data in which of five patients seen with positive margins,
three died during the followup period but only two devel-
oped metastatic disease. Interestingly, in our 46 patients
with negative margins, 13 developed metastases and 10
died during the followup period.
In our study, positive surgical margins were associated
with a higher likelihood of local recurrence in multivariate
analysis, which is in agreement with previous studies. Li
et al. [11] showed that positive margins not only had a
higher local recurrence rate, but was also a negative
prognostic factor for local recurrence in multivariate ana-
lysis. However, in comparison to our patient cohort, this
study included patients with osteosarcomas located in the
pelvis and thorax, where positive margins can be more
common secondary to anatomic constraints and complex
anatomy. Bacci et al. [1] also noted that after multivariate
analysis, surgical margins resulted in an independent
prognostic factor for local recurrence. However, they noted
that marginal margins were considered inadequate and at a
higher risk of local recurrence. In contrast, our study
showed that negative margins B 1 mm, which could be
considered a marginal margin, did not show an increased
likelihood of local recurrence compared with margins
greater than 1 mm with the numbers we had available for
study. This is supported by Li et al. [11] in which close
margins (5 mm or less) compared with wider margins
(greater than 5 mm) did not increase the likelihood of local
recurrence as well as by Bispo et al. [3] where no differ-
ence in local recurrence was detected between margins less
than 2 mm and margins greater than 2 mm.
There was no association between margin status and the
development of distant metastatic disease after surgical
resection with the numbers we had available for our study.
There is little in the way of prior research evaluating this
exact relationship. Grimer et al. [7] looked at 202 patients
and found no prognostic factors for the development of
metastatic disease. The overall rate of metastatic disease in
that study was 50% at a mean of 15 months after diagnosis.
Kim et al. [10] developed a nomogram to predict the
probability for the development of metastatic disease in
patients with Stage IIB osteosarcoma including such vari-
ables as tumor percent necrosis, location, presence of intra-
or extraarticular joint extension, and alkaline phosphatase
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level at diagnosis. They did not include margin status and
stated that the association between incomplete surgical
resections and the development of metastatic disease has
not been proven. However, as mentioned in our limitations,
more patient numbers are needed to fully elucidate this
relationship because we were able to show a decreased
overall survival with positive margins and patients die of
metastatic disease with primary extremity osteosarcoma.
Our study showed that patients with a positive margin had
aworse overall survival probability at 5 years comparedwith
those with negative margins and that, after adjusting for
confounding variables, positive margins were an indepen-
dent prognostic factor in predicting overall survival.
Whether surgical margin correlates with overall survival in
patients with osteosarcoma is controversial. Inadequate
surgical margins have been found to be associated with
overall worse event-free survival in extremity osteosarco-
mas but were not associated with decreased overall survival
[11]. Other studies have also found no association between
surgicalmargins and overall survival. Ford et al. [5] looked at
a total of 428 patients across two large orthopaedic oncology
centers and found that adequacy of surgical margins was not
associated with overall survival. However, margins were
graded qualitatively (intralesional, marginal, wide, and
radical) versus quantitatively and the length of followup was
not recorded. Thus, it is possible that patientswith positive or
close margins who developed local recurrence were treated
elsewhere thereby not allowing for a relationship between
surgical margin and overall survival to be identified. The
literature is scant of the presence of microscopic positive
margins,whichwere all positivemargins in our series, and its
relationship to overall survival. However, incomplete sur-
gical resection with retained macroscopic disease showed a
15% overall survival rate at 5 years with a relative risk of
overall survival of 3.60 when compared with complete sur-
gical resection with negative margins [2].
In conclusion, we found that patients with positive
margins in extremity, nonmetastatic, high-grade osteosar-
coma were more likely to develop a local recurrence and
had a worse overall survival predicted at 2 years than did
patients with negative margins. We could not show a re-
lationship between margin and metastatic rate, which is
counterintuitive and likely relates to insufficient statistical
power related to our small sample size. Further studies with
more numbers of patients are necessary to confirm these
preliminary observations. Even so, we believe surgeons
should strive to obtain negative margins while attempting
to maximize function and quality of life.
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